{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/1221_US20240024646A1.pdf"}, "page_content": "[0115] FIG. 3B shows a plot of fluorescence intensity in the cytotoxicity test of the NIH 3T3 cells over 24 hours of incubation with different microneedle patches as in FIG. 3A;\n\n[0116] FIG. 3C shows in vitro cellular responses of C2C12 cells after being subjected to electrostimulation (+ES) by the present device over a period of 24 hours;\n\n[0117] FIG. 3D shows scratch area ratio of the control (-ES) and electrostimulation (+ES) groups over the 24-h period as shown in FIG. 3C;\n\n[0118] FIG. 4A shows fluorescent images of agar gel inserted by PLGA II microneedles and PLAG II/Rho microneedles according to various embodiments of the present invention;\n\n[0119] FIG. 4B shows the fluorescent intensity of yellow area as shown in FIG. 4A;\n\nsquare\n\n[0120] FIG. 4C shows representative fluorescence images muscle histology from a small animal recipient post- PLGA/Rho MN penetration after 24 hours\n\nof\n\n[0121] FIG. 4D shows a drug release ratio of aspirin and ibuprofen from PLGA microneedles according to certain embodiments of the present invention in PBS solution at 37\u00b0 Cy\n\n[0122] FIG. 5A shows images of an implantation surgery the present device in a small animal recipient according certain embodiments of the present invention;\n\nof\n\nto\n\n[0123] FIG. 5B shows images of muscle morphology of the small animal recipient as shown in FIG. 5A after injury created for 5 days and 9 days (identified by broken line circles); scale bar: 5 mm;\n\n[0124] FIG. 5C representative H&E staining section images of injury induced in the small animal recipient as in FIGS. 5A and 5B after 5 days and 9 days\n\n[0125] FIG. 5D shows static injury depth on the muscle of small animal recipient as in FIGS. 5A to 5C at day 5 and 9, respectively; n=4, p<0.05, 0.01;\n\nthe day\n\n[0126] FIG. 6A shows images of dissolution of a biore- sorbable device according to certain embodiments of the present invention being immersed in PBS (pH=7.4) at 37\u00b0C. for a period of about 7 weeks;", "type": "Document"}}